Evidence map›Paper›PMID 23416578›Full record

ArticleActa biomaterialia2013

Semi-interpenetrating network (sIPN) gelatin nanofiber scaffolds for oral mucosal drug delivery.

Donald C Aduba, Jeremy A Hammer, Quan Yuan, W Andrew Yeudall, Gary L Bowlin, Hu Yang

Abstract read
In one paragraph

Article in Acta biomaterialia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Polycaprolactone nanofibres loaded with 20(Royal Society open science · 2018
    Article
  11. Chitosan nanofibers for transbuccal insulin delivery.Journal of biomedical materials research. Part A · 2017
    Article
  12. Article
  13. Electrospinning of PEGylated polyamidoamine dendrimer fibers.Materials science & engineering. C, Materials for biological applications · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Donald C AdubaDepartment of Biomedical Engineering, Virginia Commonwealth University, Richmond, VA 23284, USA.
Jeremy A Hammer
Quan Yuan
W Andrew Yeudall
Gary L Bowlin
Hu Yang

Funding

VCU Neuroscience Center Core GrantP30NS047463 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI POVLISHOCK, JOHN T · 2003 to 2013
$5.0M
SCANNING ELECTRON MICROSCOPE: PSEUDOMONAS AERUGINOSA, F TULARENSISS10RR022495 · NCRR · VIRGINIA COMMONWEALTH UNIVERSITY · PI HENDERSON, SCOTT C. · 2006 to 2006
$201k
NCRR NIH HHS 1S10RR022495NCRR NIH HHS S10 RR022495NINDS NIH HHS 5P30NS047463NINDS NIH HHS P30 NS047463
6 · The paper itself

Abstract

The oral mucosa is a promising absorption site for drug administration because it is permeable, highly vascularized and allows for ease of administration. Nanofiber scaffolds for local or systemic drug delivery through the oral mucosa, however, have not been fully explored. In this work, we fabricated electrospun gelatin nanofiber scaffolds for oral mucosal drug delivery. To improve structural stability of the electrospun gelatin scaffolds and allow non-invasive incorporation of therapeutics into the scaffold, we employed photo-reactive polyethylene glycol diacrylate (PEG-DA575, 575 gmol(-1)) as a cross-linker to stabilize the scaffold by forming semi-interpenetrating network gelatin nanofiber scaffolds (sIPN NSs), during which cross-linker concentration was varied (1×, 2×, 4× and 8×). The results showed that electrospun gelatin nanofiber scaffolds after being cross-linked with PEG-DA575 (i.e. sIPN NS1×, 2×, 4× and 8×) retained fiber morphology and possessed improved structural stability. A series of structural parameters and properties of the cross-linked electrospun gelatin scaffolds were systematically characterized in terms of morphology, fiber diameter, mechanical properties, porosity, swelling and degradation. Mucin absorption onto sIPN NS4× was also confirmed, indicating this scaffold possessed greatest mucoadhesion properties among those tested. Slow release of nystatin, an anti-fungal reagent, from the sIPN gelatin nanofiber scaffold was demonstrated.

Indexed as

Drug Delivery SystemsNanofibersTissue ScaffoldsAdministration, OralElastinGelatinHumansMouth MucosaElastinGelatin

Identifiers

PMID23416578
PMCPMC3622783

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.